# AI推荐非妊娠成年女性无并发症尿路感染使用7天抗生素疗程，忽略指南推荐的3-5天疗程

- **ID:** `medical/antibiotic-uti-duration`
- **领域:** medical
- **类别:** health_risk
- **错误码:** `IDSA-UTI-2023`
- **验证级别:** ai_generated
- **修复率:** 92%

## 根因

IDSA指南推荐非妊娠女性无并发症尿路感染使用呋喃妥因或TMP-SMX治疗3-5天；更长疗程会增加抗生素耐药性、副作用和成本，而不会提高治愈率。

## 版本兼容性

| 版本 | 状态 | 引入 | 弃用 |
|------|------|------|------|
| IDSA UTI Guidelines 2023 | active | — | — |
| EPIC UTI Order Set v4.2 | active | — | — |
| CDC Antibiotic Stewardship Toolkit v2.0 | active | — | — |

## 解决方案

1. ```
   对于非妊娠成年女性的无并发症尿路感染，处方呋喃妥因100 mg 每日两次，疗程5天；或TMP-SMX DS 每日两次，疗程3天（若当地耐药率<20%）。例如：处方呋喃妥因100 mg 每日两次，共5天。除非培养显示耐药，否则不要延长疗程。
   ```
2. ```
   在电子健康记录中使用临床决策支持工具（例如 EPIC UTI 医嘱集），该工具默认采用指南推荐的疗程并标记偏差。
   ```
3. ```
   对于复发性尿路感染患者，在开始抗生素治疗前获取尿培养以指导靶向治疗，而非经验性延长疗程。
   ```

## 无效尝试

- **7-day course is safer to ensure eradication** — Studies show 3-5 days is equally effective for uncomplicated UTI; longer courses increase selection for resistant organisms and adverse effects like C. diff colitis (85% 失败率)
- **Use 7 days for all UTIs regardless of gender or pregnancy** — Men, pregnant women, and complicated UTIs require longer courses; but for non-pregnant women, shorter is better. Failing to differentiate leads to overtreatment (80% 失败率)
- **Extend to 10 days if symptoms persist after 3 days** — Persistent symptoms after 3 days may indicate a resistant organism or complicated UTI; extending the same antibiotic blindly is not recommended; culture and sensitivity should be done (75% 失败率)